Unconfirmed Rumors circulate that (JNJ) is in final stages to acquire (BSX) at $9.50 a share

Unconfirmed Rumors circulate that (JNJ) is in final stages to acquire (BSX) at $9.50 a share..
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsRumorsM&AHealth CareHealth Care EquipmentPharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!